Summit Therapeutics, Inc. (SMMT)
14.34
+0.11
(+0.77%)
USD |
NASDAQ |
Aug 27, 16:00
14.30
-0.04
(-0.28%)
After-Hours: 20:00
Summit Therapeutics EPS Diluted (TTM) : -1.119 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.119 |
| March 31, 2026 | -1.604 |
| December 31, 2025 | -1.445 |
| September 30, 2025 | -1.242 |
| June 30, 2025 | -1.007 |
| March 31, 2025 | -0.3309 |
| December 31, 2024 | -0.3076 |
| September 30, 2024 | -0.2768 |
| June 30, 2024 | -0.2299 |
| March 31, 2024 | -0.1657 |
| December 31, 2023 | -1.538 |
| September 30, 2023 | -1.577 |
| June 30, 2023 | -1.690 |
| March 31, 2023 | -1.838 |
| December 31, 2022 | -0.6215 |
| September 30, 2022 | -0.8068 |
| June 30, 2022 | -0.864 |
| March 31, 2022 | -0.965 |
| December 31, 2021 | -0.958 |
| September 30, 2021 | -0.8456 |
| June 30, 2021 | -0.9084 |
| March 31, 2021 | -0.8664 |
| December 31, 2020 | -0.668 |
| September 30, 2020 | -0.504 |
| June 30, 2020 | -0.2401 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0128 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | -0.065 |
| July 31, 2019 | -0.1936 |
| April 30, 2019 | 0.2351 |
| January 31, 2019 | 0.1282 |
| October 31, 2018 | -0.0135 |
| July 31, 2018 | 0.0979 |
| April 30, 2018 | -0.3953 |
| January 31, 2018 | -0.3883 |
| October 31, 2017 | -0.2809 |
| July 31, 2017 | -0.3537 |
| April 30, 2017 | -0.4287 |
| January 31, 2017 | -0.4573 |
| October 31, 2016 | -0.4768 |
| July 31, 2016 | -0.5101 |
| April 30, 2016 | -0.4793 |
| January 31, 2016 | -0.4413 |
| October 31, 2015 | -0.4311 |
| July 31, 2015 | -0.3078 |
| April 30, 2015 | -0.1991 |
| January 31, 2015 | -0.1086 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| NovelStem International Corp. | -0.0064 |
| Brainstorm Cell Therapeutics, Inc. | -0.9541 |
| Kezar Life Sciences, Inc. | -6.176 |
| Protara Therapeutics, Inc. | -1.354 |
| Clene, Inc. | -3.512 |